Limitation to the use of the urinary S-/R-mephenytoin ratio in pharmacogenetic studies
- PMID: 2054275
- PMCID: PMC1368365
- DOI: 10.1111/j.1365-2125.1991.tb05542.x
Limitation to the use of the urinary S-/R-mephenytoin ratio in pharmacogenetic studies
Abstract
The reproducibility of the S-/R-mephenytoin ratio was examined in urines stored at -20 degrees C over 2 years. Large changes in this ratio were observed in some urine samples stored for only a few months under these conditions. The changes observed in the S-/R-mephenytoin ratio are attributed to the decomposition of an acid labile metabolite of S-mephenytoin which is eliminated in the urine. The instability of this metabolite makes it desirable to process urine shortly after its collection in order to avoid inaccurate phenotype assignments based upon the urinary S-/R-mephenytoin ratio. If rapid processing of urines is impractical, additional methods are described for preventing improper phenotype assignment of subjects.
Similar articles
-
Polymorphic metabolism of mephenytoin in man: pharmacokinetic interaction with a co-regulated substrate, mephobarbital.Clin Pharmacol Ther. 1986 Jun;39(6):646-53. doi: 10.1038/clpt.1986.113. Clin Pharmacol Ther. 1986. PMID: 3709029
-
Analysis of mephenytoin, 4-hydroxymephenytoin and 4-hydroxyphenytoin enantiomers in human urine by cyclodextrin micellar electrokinetic capillary chromatography: simple determination of a hydroxylation polymorphism in man.Electrophoresis. 1994 Jan;15(1):87-93. doi: 10.1002/elps.1150150113. Electrophoresis. 1994. PMID: 8143685
-
[Determination of R- and S-mephenytoin in human urine by gas chromatography].Se Pu. 1997 Sep;15(5):408-10. Se Pu. 1997. PMID: 15739491 Chinese.
-
S-mephenytoin hydroxylation phenotypes in a Jordanian population.Clin Pharmacol Ther. 1995 Nov;58(5):542-7. doi: 10.1016/0009-9236(95)90174-4. Clin Pharmacol Ther. 1995. PMID: 7586948 Clinical Trial.
-
[A chiral capillary gas chromatographic method for direct determination of enantiomers of mephenytoin in human urine].Yao Xue Xue Bao. 1993;28(4):307-11. Yao Xue Xue Bao. 1993. PMID: 8213176 Chinese.
Cited by
-
Debrisoquine and mephenytoin oxidation in Sinhalese: a population study.Br J Clin Pharmacol. 1994 Nov;38(5):466-70. doi: 10.1111/j.1365-2125.1994.tb04384.x. Br J Clin Pharmacol. 1994. PMID: 7893590 Free PMC article.
-
Drug interactions and the cytochrome P450 system. The role of cytochrome P450 2C19.Clin Pharmacokinet. 1995;29 Suppl 1:45-52. doi: 10.2165/00003088-199500291-00008. Clin Pharmacokinet. 1995. PMID: 8846622 Review.
-
The N-demethylation of imipramine correlates with the oxidation of S-mephenytoin (S/R-ratio). A population study.Br J Clin Pharmacol. 1993 Mar;35(3):331-4. Br J Clin Pharmacol. 1993. PMID: 8471415 Free PMC article.
-
Assessment of urinary mephenytoin metrics to phenotype for CYP2C19 and CYP2B6 activity.Eur J Clin Pharmacol. 2008 Apr;64(4):387-98. doi: 10.1007/s00228-007-0416-z. Epub 2007 Dec 11. Eur J Clin Pharmacol. 2008. PMID: 18071681
-
Proguanil metabolism is determined by the mephenytoin oxidation polymorphism in Vietnamese living in Denmark.Br J Clin Pharmacol. 1993 Aug;36(2):105-8. doi: 10.1111/j.1365-2125.1993.tb04204.x. Br J Clin Pharmacol. 1993. PMID: 8398577 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources